Literature DB >> 1065618

Non-random karyotypic evolution in chronic myeloid leukemia.

F Mitelman, G Levan, P G Nilsson, L Brandt.   

Abstract

The chromosome banding pattern was analyzed in bone-marrow cells and/or spleen cells of 10 patients in the blastic phase of chronic myeloid leukemia (CML). It was obvious from the karyotype analysis that the chromosome aberrations occurring addition to the Philadelphia chromosome (Ph1) were strictly non-random. An extra Ph1, trisomy 8 and/or trisomy for the long arm of chromosome 17 were observed in all cases. This consistent pattern of chromosome involvement in CML was confirmed in 57 cases from the literature studied with banding techniques. In 88% of the total number of cases with further changes at least one of the three main chromosomal aberrations was found ("major route" of karyotypic evolution).

Entities:  

Mesh:

Year:  1976        PMID: 1065618     DOI: 10.1002/ijc.2910180105

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  22 in total

Review 1.  Applying the discovery of the Philadelphia chromosome.

Authors:  Daniel W Sherbenou; Brian J Druker
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

2.  Oncogenes result in genomic alterations that activate a transcriptionally silent, dominantly selectable reporter gene (neo).

Authors:  R E Drews; V T Chan; L E Schnipper
Journal:  Mol Cell Biol       Date:  1992-01       Impact factor: 4.272

3.  Novel Cytogenetic Aberrations in a Patient of Chronic Myeloid Leukemia with Blast Crisis.

Authors:  Bhoumik Shah; Smeeta Gajendra; Ritu Gupta; Atul Sharma
Journal:  J Clin Diagn Res       Date:  2015-05-01

Review 4.  Genetic events other than BCR-ABL1.

Authors:  Paolo Neviani
Journal:  Curr Hematol Malig Rep       Date:  2014-03       Impact factor: 3.952

5.  Secondary activation of c-abl may be related to translocation to the nucleolar organizer region in an in vitro cultured rat leukemia cell line (K3D).

Authors:  R Takahashi; K Mihara; S Maeda; T Yamaguchi; H L Chen; N Aoyama; S Murao; M Hatanaka; T Sugiyama
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

Review 6.  Potential mechanisms of disease progression and management of advanced-phase chronic myeloid leukemia.

Authors:  Elias J Jabbour; Timothy P Hughes; Jorge E Cortés; Hagop M Kantarjian; Andreas Hochhaus
Journal:  Leuk Lymphoma       Date:  2013-11-12

Review 7.  [Chromosomal abnormalities in human neoplasia (author's transl)].

Authors:  C R Bartram; H W Rüdiger
Journal:  Klin Wochenschr       Date:  1978-08-01

8.  Individual telomere lengths in chronic myeloid leukemia.

Authors:  Oumar Samassekou; Aimé Ntwari; Josée Hébert; Ju Yan
Journal:  Neoplasia       Date:  2009-11       Impact factor: 5.715

9.  Relevance of trisomy 15 and other chromosome abnormalities in spontaneous AKR leukemia of mice with and without Robertsonian rearrangement.

Authors:  E W Herbst; A Gropp
Journal:  J Cancer Res Clin Oncol       Date:  1982       Impact factor: 4.553

10.  Investigations on karyotype evolution in patients with chronic myeloid leukemia (CML).

Authors:  O A Haas; J D Schwarzmeier; E Nacheva; P Fischer; E Paietta
Journal:  Blut       Date:  1984-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.